期刊文献+

新疆癫痫患儿HLA-B基因多态性与奥卡西平所致斑丘疹的相关性研究 被引量:4

Relationship between HLA-B gene polymorphism and macular papule caused by oxcarbazepine in epileptic children in Xinjiang
原文传递
导出
摘要 目的:探讨我国新疆癫痫患儿HLA-B基因多态性与奥卡西平(oxcarbazepine,OXC)引起斑丘疹的相关性。方法:收集服用OXC后引起斑丘疹16例和未发生斑丘疹的135例癫痫患儿,采用第二代测序技术对151例癫痫患儿的HLA-B等位基因进行全基因组测序,分析OXC引起的斑丘疹与HLA-B基因多态性的相关性。结果:OXC-MPE组、OXC-耐受组和一般人群的HLA-B*0702基因型频率分别为:28.13%(9/32),2.43%(9/370)和2.14%(103/4816)。HLA-B*0702的等位基因阳性率在OXC-MPE组、OXC-耐受组和一般人群之间的差异均具有统计学意义(P<0.01,OR=26.51,95%CI:4.40~82.58;P<0.01,OR=27.45,95%CI:13.08~57.65)。HLA-B*4032的等位基因阳性率在OXC-MPE组、OXC-耐受组和一般人群之间的差异均具有统计学意义(P<0.05,OR=6.19,95%CI:0.90~0.99)。此外,OXC-MPE组,OXC-耐受组和一般人群的HLA-B*4001基因型频率分别为:0%(0/32),3.78%(14/370)和0.53%(27/5117)。HLA-B*4001的等位基因阳性率在OXC-MPE组和OXC-耐受组之间的差异有统计学意义(P<0.05,OR=4.08,95%CI:1.00~9.08)。结论:我国新疆癫痫患儿中HLA-B*0702和HLA-B*4032等位基因可能是OXC诱发斑丘疹的风险等位基因,其中HLA-B*0702等位基因的风险度较大。 OBJECTIVE To explore the relationship between HLA-B gene polymorphism and macular papule caused by oxcarbazepine in Han epileptic children in Xinjiang.METHODS Sixteen cases of maculopapular eruption(MPE)caused by oxcarbazepine(OXC)and 135 Han epileptic children without MPE were recruited.Next-generation sequencing was employed for sequencing whole genome of HLA-B alleles in 151 epileptic children and correlation between macular papule caused by oxcarbazepine and HLA-B gene polymorphism was analyzed.RESULTS The frequencies of HLA-B*0702 genotypes in OXC-MPE group,OXC-/tolerance group and general population were 28.13%(9/32),2.43%(9/370)and 2.14%(103/4816)respectively.Significant differences existed in positive rate of HLA-B*0702 allele between OXC-MPE group,OXC-tolerance group and general population(P<0.01,OR=26.51,95%CI:4.40-82.58,P<0.01,OR=27.45,95%CI:13.08-57.65).Significant differences existed in positive rate of HLA-B*4032 allele among OXC-MPE group,OXC-tolerance group and general population(P<0.05,OR=6.19,95%CI:0.90-0.99).In addition,the frequencies of HLA-B*4001 genotypes in OXC-MPE group,OXC-tolerance group and general population were 0%(0/32),3.78%(14/370)and 0.53%(27/5117)respectively.Significant difference existed in positive rate of HLA-B*4001 allele between OXC-MPE and OXC-tolerance group(P<0.05,OR=4.08,95%CI:1.00-9.08).CONCLUSION HLA-B*0702 and HLA-B*4032 alleles may be the risk genes of macular papule induced by OXC in epileptic children in Xinjiang and the risk of HLA-B*0702 allele is higher.
作者 于鲁海 李红健 赵婷 王婷婷 贾莉 玛尔江·巴合提别克 刘文丽 孙岩 孙力 于爱平 YU Lu-hai;LI Hong-jian;ZHAO Ting;WANG Ting-ting;JIA Li;BAHATIBIEKE Ma-er-jiang;LIU Wen-li;SUN Yan;SUN Li;YU Ai-ping(Department of Pharmacy,Xinjiang Urumqi 830001,China;Department of Pediatrics,Xinjiang Urumqi 830001,China;Administrative Office,People's Hospital of Xinjiang Uygur Autonomous Region,Xinjiang Urumqi 830001,China)
出处 《中国医院药学杂志》 CAS 北大核心 2021年第1期13-16,41,共5页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金资助项目(编号:81460571)。
关键词 奥卡西平 斑丘疹 HLA-B 癫痫患儿 oxcarbazepine maculopapular eruption HLA-B epileptic children
  • 相关文献

参考文献3

二级参考文献48

  • 1付永娟,朴月善,卢德宏.难治性癫的神经病理学特点[J].卒中与神经疾病,2006,13(1):62-64. 被引量:7
  • 2吴洵昳,洪震,吴逊,吴立文,赵忠新,王学峰,周东,吕传真.多中心双盲、随机、安慰剂对照评价左乙拉西坦添加治疗难治性部分性癫癎发作的疗效及安全性[J].中华神经科杂志,2007,40(3):149-153. 被引量:44
  • 3李劲梅,王学峰,肖飞,曾艳,林涛,席志芹.自身对照左乙拉西坦添加治疗耐药性癫痫部分性发作的疗效及安全性[J].中国新药与临床杂志,2007,26(5):381-384. 被引量:12
  • 4LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review[J]. J Am Med Assoc, 2004, 291 (5) : 605-614.
  • 5LaRoche SM, Helmers SL. The new antiepileptic drugs clinical applications[J]. J Am Med Assoc, 2004, 291 (5) 615-620.
  • 6Hitiris N, Brodie MJ. Modem antiepileptic drugs: guidelines and beyond[J]. Curr Opin Neurol, 2006, 19 (2) : 175-180.
  • 7French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society [J]. Neurology, 2004, 62 (8): 1252-1260.
  • 8National Institute for Health and Clinical Excellence. Technology appraisal guidance 76: newer drugs for epilepsy in adults [EB/OL]. (2005-07-05) [2011-07-05]. http://www. nice.org.uk/TA076guidance.
  • 9National Collaborating Centre for Primary Care. The diagnosis and management of the epilepsies in adults and children in primary and secondary care EEB/OL]. (2005- 07-05) [2011-07-05]. http://www.rcgp.org.uk/nccpc/docs/ guidelines_epilepsies.pdf, and at http://www.nice.org.uk/pdf/ CG020NICEguideline.pdf.
  • 10Frost S, Crawford P, Mera S, et al. National statement of good practice for the treatment and care of people who have epilepsy. Joint Epilepsy Council 2002 [EB/OL]. (2005-07- 05) [2011-07-05]. http://www.jointepilepsycouncil.org.uk/ nsgoodprac.asp.

共引文献37

同被引文献29

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部